GRENOBLE, France and FRANKLIN, Tenn., Sept. 1, 2026 /PRNewswire/ — eCential Robotics, a leading developer of enabling technologies and surgical robotics, today announced that Enovis™ Corporation (NYSE: ENOV) has entered a binding offer to acquire the company.
Following completion of the information and consultation process with eCential Robotics’ works council in accordance with French law, the parties expect to enter into a definitive purchase agreement. The transaction is expected to close during the fourth quarter of 2026, subject to regulatory approvals.
Founded on more than 15 years of innovation in computer-assisted surgery and orthopedic robotics, eCential Robotics has developed a modular platform designed to advance the next generation of robotic-assisted surgery. The company’s expertise in robotics engineering, software development, and surgical automation complements Enovis’ existing technology portfolio while adding capabilities that meaningfully accelerate its innovation roadmap. The company’s Op.n® platform brings surgical navigation and active robotics together in a single architecture and is FDA 510(k)-cleared for spine surgery in the United States and serves as a proven foundation for future innovation. The acquisition strengthens and expands the Enovis ASTRA™ enabling technology ecosystem with robotic automation capabilities, creating a more comprehensive ecosystem designed to improve surgical precision, streamline workflows, and enhance patient outcomes.
Clément Vidal, Chief Executive Officer of eCential Robotics, said: “Our strategy at eCential Robotics has always been to offer surgeons easy-to-use, cutting-edge technology to improve surgical workflows, and ultimately, enable better patient outcomes. As part of Enovis, we will be able to grow through a shared mission to support surgeons with greater operating room efficiency, and help patients live more full, active lives. I am truly excited about the opportunities we will unlock together.”
“This acquisition is a significant milestone and reflects our disciplined approach to bringing externally developed innovation into Enovis. The eCential Robotics team brings exceptional engineering talent, intellectual property and a proven track record of bringing innovative robotic solutions to market. Their expertise will serve as the bedrock of our robotics strategy and enable Enovis to win in surgical enabling technology,” said Damien McDonald, Chief Executive Officer of Enovis. “eCential Robotics’ surgical robotics platform is a natural complement to our ARVIS® Augmented Reality System, and will give surgeons a broader set of robotic solutions, aiming to improve precision, streamline workflows in the operating room and deliver better outcomes for patients.”
Stéphane Lavallée, Founder and Chair of eCential Robotics added, “I could not be more excited about this next chapter. Enovis brings focus, speed, and a real commitment to the future of eCential Robotics. Together, the combined companies will continue to support existing partnerships and build a center of excellence for robotics in Grenoble focused on advancing the shared innovation roadmap.”
eCential Robotics remains committed to supporting collaboration with spine implant partners in the deployment of eCential Robotics’ newly FDA-cleared Op.n® Spine Navigation and Robotic Guidance Platform.
eCential Robotics has pursued a vision of expanding a single technology platform across multiple orthopedic indications. Combining eCential Robotics’ scalable platform with Enovis’ orthopedic portfolio and global reach is expected to significantly accelerate that vision and broaden access to robotic-assisted surgery.
In connection with this transaction, Apparius (Henri de Lalande, Yoann Foray) is acting as exclusive financial advisor to eCential Robotics and Goodwin France (Thomas Dupont-Sentilles, Johann Gandillon) and Cabinet Franck Robert (Franck Robert) are acting as legal counsel.
About eCential Robotics
eCential Robotics is a French medical technology company pioneering robotic and navigation solutions for orthopedic surgery, enabling greater surgical precision, workflow efficiency, and seamless collaboration offering procedural flexibility. The company is headquartered in Gières, France, with US commercial operations in Franklin, Tennessee. Learn more at www.ecential-robotics.com
About Enovis
Enovis™ (NYSE: ENOV) is a global medical technology innovator dedicated to improving lives by developing clinically differentiated solutions that enhance patient outcomes and restore motion for life. We partner with the brightest minds in health to advance care that is smarter, personalized, and more effective, while improving operational efficiency for surgeons and clinicians around the world. Enovis solutions impact the well-being of millions of patients wherever they are on their pathway to health. Discover more about Enovis at www.enovis.com and follow us on Facebook, Instagram, LinkedIn and X.
CONTACT: clement.vidal@ecential-robotics.com
SOURCE eCential Robotics